LFWD News

Stocks

Headlines

Earnings Forecasts Reveal Mixed Results for Key Companies

Earnings Forecasts Reveal Mixed Results for Key Companies. Companies preparing to report earnings show significant discrepancies in EPS forecasts, impacting future stock prices.

Date: 
AI Rating:   4

Overview of Earnings Reports
Several companies are slated to report their earnings, with significant expectations for various sectors. The report chiefly highlights the projected earnings per share (EPS), which plays a crucial role in determining stock prices and investor sentiment.

Algonquin Power & Utilities Corp. (AQN)
The consensus EPS forecast is $0.08, indicating a substantial decrease of 50.00% compared to the same quarter last year. Additionally, AQN missed its previous EPS forecast by 6.67%. The 2024 Price to Earnings (P/E) ratio stands at 12.68, which is considerably lower than the industry ratio of 19.40, potentially portraying weaker performance relative to its competitors.

Advantage Solutions Inc. (ADV)
The EPS forecast is projected at -$0.06, signifying a drastic drop of 200.00% from the previous year. Also, its P/E ratio is reported at -4.69, which may further indicate a problematic position within the market context as they report negative earnings.

Genesco Inc. (GCO)
GCO presents a more positive outlook with an EPS forecast of $3.31, reflecting a 27.80% increase from the same quarter last year. However, the P/E ratio of 34.69 is significantly higher than the industry average of 9.60, suggesting that while earnings growth is expected, it may not translate to favorable stock valuation.

WhiteHorse Finance, Inc. (WHF)
The EPS forecast is at $0.39, with a decrease of 15.22% from the previous year, coupled with a negative trend in their last reported quarters. Its P/E ratio stands at 6.50, which is lower than the industry’s 9.50, hinting at possible challenges ahead for WHF.

inTest Corporation (INTT)
The consensus EPS forecast here is $0.14, albeit with a 12.50% decrease compared to the previous year and missing the last forecast by 46.67%, reflecting a trend of declining performance.

Oncolytics Biotech Inc. (ONCY)
This biotech company expects an EPS of -$0.08, indicating a 100.00% decrease from last year’s figures, with a P/E ratio being negative also suggesting substantial challenges ahead.

Lifeward Ltd. (LFWD)
LFWD’s EPS forecast is $-0.20; even with a 42.86% increase compared to last year, the negative EPS points to ongoing troubles, while its P/E ratio of -0.97 could indicate a concerning situation against an industry rate of -80.70.